Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Canadian guideline on genetic screening for hereditary renal cell cancers.
Reaume MN, Graham GE, Tomiak E, Kamel-Reid S, Jewett MA, Bjarnason GA, Blais N, Care M, Drachenberg D, Gedye C, Grant R, Heng DY, Kapoor A, Kollmannsberger C, Lattouf JB, Maher ER, Pause A, Ruether D, Soulieres D, Tanguay S, Turcotte S, Violette PD, Wood L, Basiuk J, Pautler SE; Kidney Cancer Research Network of Canada. Reaume MN, et al. Among authors: lattouf jb. Can Urol Assoc J. 2013 Sep-Oct;7(9-10):319-23. doi: 10.5489/cuaj.1496. Can Urol Assoc J. 2013. PMID: 24319509 Free PMC article.
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.
Lacombe L, Hovington H, Brisson H, Mehdi S, Beillevaire D, Émond JP, Wagner A, Villeneuve L, Simonyan D, Ouellet V, Barrès V, Latour M, Aprikian A, Bergeron A, Castonguay V, Couture F, Chevalier S, Brimo F, Fazli L, Fleshner N, Gleave M, Karakiewicz PI, Lattouf JB, Trudel D, van der Kwast T, Mes-Masson AM, Pouliot F, Fradet Y, Audet-Walsh E, Saad F, Guillemette C, Lévesque E. Lacombe L, et al. Among authors: lattouf jb. Cancer Lett. 2023 Jan 28;553:215994. doi: 10.1016/j.canlet.2022.215994. Epub 2022 Nov 4. Cancer Lett. 2023. PMID: 36343786
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada.
Metcalfe M, Kassouf W, Rendon R, Bell D, Izawa J, Chin J, Kapoor A, Matsumoto E, Lattouf JB, Saad F, Lacombe L, Fradet Y, Fairey A, Jacobson NE, Drachenberg D, Cagiannos I, So A, Black P. Metcalfe M, et al. Among authors: lattouf jb. Can Urol Assoc J. 2012 Dec;6(6):455-62. doi: 10.5489/cuaj.12146. Can Urol Assoc J. 2012. PMID: 23282664 Free PMC article.
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A, Kapoor A, Black P, Lacombe L, Tanguay S, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Izawa JI. Williams AK, et al. Among authors: lattouf jb. Urol Oncol. 2013 Oct;31(7):1161-5. doi: 10.1016/j.urolonc.2011.12.004. Epub 2013 Feb 13. Urol Oncol. 2013. PMID: 23415596
Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
Yafi FA, Tanguay S, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Lacombe L, Chin J, So A, Lattouf JB, Bell D, Fradet Y, Saad F, Matsumoto E, Drachenberg D, Cagiannos I, Kassouf W. Yafi FA, et al. Among authors: lattouf jb. Urol Oncol. 2014 Jan;32(1):31.e17-24. doi: 10.1016/j.urolonc.2012.11.014. Epub 2013 Feb 18. Urol Oncol. 2014. PMID: 23428535
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.
North S, Basappa N, Bjarnason G, Blais N, Canil C, Heng D, Knox J, Reaume N, Ruether D, Soulières D, Zalewski P, Black P, Breau RH, Jewett M, Kapoor A, Lattouf JB, Moore R, Rendon R, Todd G, Pituskin E, Gedye C, Wood L. North S, et al. Among authors: lattouf jb. Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536. Can Urol Assoc J. 2013. PMID: 24032057 Free PMC article. No abstract available.
Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Sheyegan B, Drachenberg D, Cagiannos I, Lacombe L. Fradet V, et al. Among authors: lattouf jb. Urol Oncol. 2014 Aug;32(6):839-45. doi: 10.1016/j.urolonc.2014.04.006. Epub 2014 May 22. Urol Oncol. 2014. PMID: 24856978
The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence.
Kapoor A, Dason S, Allard CB, Shayegan B, Lacombe L, Rendon R, Jacobsen NE, Fairey A, Izawa J, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Drachenberg D, Cagiannos I, Fradet Y, Alamri A, Kassouf W. Kapoor A, et al. Among authors: lattouf jb. Can Urol Assoc J. 2014 Nov;8(11-12):E845-52. doi: 10.5489/cuaj.1985. Can Urol Assoc J. 2014. PMID: 25485014 Free PMC article.
Surgical management of stage T1 renal tumours at Canadian academic centres.
Lavallée LT, Tanguay S, Jewett MA, Wood L, Kapoor A, Rendon RA, Moore RB, Lacombe L, Kawakami J, Pautler SE, Drachenberg DE, Black PC, Lattouf JB, Morash C, Cagiannos I, Liu Z, Breau RH. Lavallée LT, et al. Among authors: lattouf jb. Can Urol Assoc J. 2015 Mar-Apr;9(3-4):99-106. doi: 10.5489/cuaj.2598. Can Urol Assoc J. 2015. PMID: 26085866 Free PMC article.
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone.
Saad F, Winquist E, Hubay S, Berry S, Assi H, Levesque E, Aucoin N, Czaykowski P, Lattouf JB, Alloul K, Stewart J, Sridhar SS. Saad F, et al. Among authors: lattouf jb. Can Urol Assoc J. 2016 Mar-Apr;10(3-4):102-9. doi: 10.5489/cuaj.3470. Can Urol Assoc J. 2016. PMID: 27217856 Free PMC article.
133 results